{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:52:56Z","timestamp":1788274376701,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0811-2","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T08:45:19Z","timestamp":1527669919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Fathia G.","family":"Jaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajidah F.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare V.","family":"Lanyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"De Soyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-0793","authenticated-orcid":false,"given":"Stephen M.","family":"Todryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"811_CR1","volume-title":"Global burden of diseases","author":"World Health Organisation","year":"2016","unstructured":"World Health Organisation. Global burden of diseases. 2016."},{"key":"811_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","volume":"4","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4:969\u201379.","journal-title":"Lancet Respir Med"},{"key":"811_CR3","first-page":"6","volume":"147","author":"PJ Cole","year":"1986","unstructured":"Cole PJ. Inflammation: a two-edged sword--the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6\u201315.","journal-title":"Eur J Respir Dis Suppl"},{"key":"811_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/thorax.57.1.15","volume":"57","author":"J Angrill","year":"2002","unstructured":"Angrill J, Agust\u00ed C, de Celis R, Ra\u00f1\u00f3 A, Gonzalez J, Sol\u00e9 T, Xaubet A, Rodriguez-Roisin R, Torres A. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax. 2002;57:15\u20139.","journal-title":"Thorax"},{"key":"811_CR5","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","volume":"101","author":"PT King","year":"2007","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Microbiologic follow-up study in adult bronchiectasis. Respir Med. 2007;101:1633\u20138.","journal-title":"Respir Med"},{"key":"811_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","volume":"187","author":"MM Tunney","year":"2013","unstructured":"Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med. 2013;187:1118\u201326.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0140-6736(14)61136-3","volume":"384","author":"RP Dickson","year":"2014","unstructured":"Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014;384:691\u2013702.","journal-title":"Lancet"},{"key":"811_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","volume":"11","author":"GB Rogers","year":"2014","unstructured":"Rogers GB, Zain NM, Bruce KD, Burr LD, Chen AC, Rivett DW, McGuckin MA, Serisier DJ. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann Am Thorac Soc. 2014;11:496\u2013503.","journal-title":"Ann Am Thorac Soc"},{"key":"811_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","volume":"68","author":"GB Rogers","year":"2013","unstructured":"Rogers GB, van der Gast CJ, Cuthbertson L, Thomson SK, Bruce KD, Martin ML, Serisier DJ. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax. 2013;68:731\u20137.","journal-title":"Thorax"},{"key":"811_CR10","doi-asserted-by":"crossref","unstructured":"Wang Z, Singh R, Miller BE, Tal-Singer R, Van Horn S, Tomsho L, Mackay A, Allinson JP, Webb AJ, Brookes AJ, George LM, Barker B, Kolsum U, Donnelly LE, Belchamber K, Barnes PJ, Singh D, Brightling CE, Donaldson GC, Wedzicha JA, Brown JR, Sputum COPDMAP. Microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study. Thorax. 2017;73:331\u201338.","DOI":"10.1136\/thoraxjnl-2017-210741"},{"key":"811_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","volume":"109","author":"MJ McDonnell","year":"2015","unstructured":"McDonnell MJ, Jary HR, Perry A, MacFarlane JG, Hester KL, Small T, Molyneux C, Perry JD, Walton KE, De Soyza A. Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med. 2015;109:716\u201326.","journal-title":"Respir Med"},{"key":"811_CR12","doi-asserted-by":"crossref","unstructured":"Jones CJ, Wozniak DJ. Psl produced by mucoid Pseudomonas aeruginosa contributes to the establishment of biofilms and immune evasion. MBio. 2017;8(3)","DOI":"10.1128\/mBio.00864-17"},{"key":"811_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1164\/ajrccm.164.9.2105083","volume":"164","author":"J Angrill","year":"2001","unstructured":"Angrill J, Agust\u00ed C, De Celis R, Filella X, Ra\u00f1\u00f3 A, Elena M, De La Bellacasa JP, Xaubet A, Torres A. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med. 2001;164:1628\u201332.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016384","volume":"6","author":"JR Erb-Downward","year":"2011","unstructured":"Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB. Analysis of the lung microbiome in the \"healthy\" smoker and in COPD. PLoS One. 2011;6:e16384.","journal-title":"PLoS One"},{"issue":"1","key":"811_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2008.03596.x","volume":"152","author":"RJ Boyton","year":"2008","unstructured":"Boyton RJ, Smith J, Jones M, Reynolds C, Ozerovitch L, Chaudhry A, Wilson R, Rose M, Altmann DM. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol. 2008 Apr;152(1):95\u2013101.","journal-title":"Clin Exp Immunol"},{"key":"811_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev-pathol-012615-044344","volume":"11","author":"RJ Boyton","year":"2016","unstructured":"Boyton RJ, Altmann DM. Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology. Annu Rev Pathol. 2016;11:523\u201354.","journal-title":"Annu Rev Pathol"},{"key":"811_CR17","doi-asserted-by":"publisher","first-page":"11020","DOI":"10.1073\/pnas.0702403104","volume":"104","author":"G D\u00f6ring","year":"2007","unstructured":"D\u00f6ring G, Meisner C, Stern M. Flagella vaccine trial study group. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2007;104:11020\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"811_CR18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.vaccine.2009.10.080","volume":"28","author":"D Bumann","year":"2010","unstructured":"Bumann D, Behre C, Behre K, Herz S, Gewecke B, Gessner JE, von Specht BU, Baumann U. Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers. Vaccine. 2010;28:707\u201313.","journal-title":"Vaccine"},{"key":"811_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1164\/rccm.201202-0182OC","volume":"186","author":"W Wu","year":"2012","unstructured":"Wu W, Huang J, Duan B, Traficante DC, Hong H, Risech M, Lory S, Priebe GP. Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2012;186:420\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/CVI.00089-15","volume":"22","author":"TF Murphy","year":"2015","unstructured":"Murphy TF. Vaccines for Nontypeable Haemophilus influenzae: the future is now. Clin Vaccine Immunol. 2015;22:459\u201366.","journal-title":"Clin Vaccine Immunol"},{"key":"811_CR21","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cid\/ciu646","volume":"59","author":"C Aguilar","year":"2014","unstructured":"Aguilar C, Malphettes M, Donadieu J, et al. Prevention of infections during primary immunodeficiency. Clin Infect Dis. 2014;59:1462\u201370.","journal-title":"Clin Infect Dis"},{"key":"811_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nri3769","volume":"14","author":"BJ Marsland","year":"2014","unstructured":"Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol. 2014;14:827\u201335.","journal-title":"Nat Rev Immunol"},{"key":"811_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/imr.12183","volume":"260","author":"JP McAleer","year":"2014","unstructured":"McAleer JP, Kolls JK. Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev. 2014;260:129\u201344.","journal-title":"Immunol Rev"},{"key":"811_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","volume":"186","author":"JD Chalmers","year":"2012","unstructured":"Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012;186:657\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/thx.2010.142778","volume":"65","author":"MC Pasteur","year":"2010","unstructured":"Pasteur MC, Bilton D, Hill AT. British Thoracic Society non-CF bronchiectasis guideline group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65:577.","journal-title":"Thorax"},{"key":"811_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imm.12428","volume":"145","author":"KM Walker","year":"2015","unstructured":"Walker KM, Okitsu S, Porter DW, Duncan C, Amacker M, Pluschke G, Cavanagh DR, Hill AV, Todryk SM. Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships. Immunology. 2015;145:71\u201381.","journal-title":"Immunology"},{"key":"811_CR28","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/eji.200939434","volume":"39","author":"SM Todryk","year":"2009","unstructured":"Todryk SM, Walther M, Bejon P, Hutchings C, Thompson FM, Urban BC, Porter DW, Hill AV. Multiple functions of human T cells generated by experimental malaria challenge. Eur J Immunol. 2009;39:3042\u201351.","journal-title":"Eur J Immunol"},{"key":"811_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1164\/rccm.201312-2293OC","volume":"190","author":"SG Kalathil","year":"2014","unstructured":"Kalathil SG, Lugade AA, Pradhan V, Miller A, Parameswaran GI, Sethi S, Thanavala Y. T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;190:40\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR30","doi-asserted-by":"crossref","unstructured":"King PT, Lim S, Pick A, Ngui J, Prodanovic Z, Downey W, Choong C, Kelman A, Baranyai E, Francis M, Moshinsky R, Bardin PG, Holmes PW, Holdsworth SR. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 2013;131. 1314-21:e14.","DOI":"10.1016\/j.jaci.2012.09.030"},{"key":"811_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.001","volume":"128","author":"G Suarez-Cuartin","year":"2017","unstructured":"Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, Plaza V, Fardon TC, Sibila O, Chalmers JD. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis. Respir Med. 2017;128:1\u20136.","journal-title":"Respir Med"},{"key":"811_CR32","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1164\/rccm.201411-1995OC","volume":"191","author":"KJ Quigley","year":"2015","unstructured":"Quigley KJ, Reynolds CJ, Goudet A, Raynsford EJ, Sergeant R, Quigley A, Worgall S, Bilton D, Wilson R, Loebinger MR, Maillere B, Altmann DM, Boyton RJ. Chronic infection by mucoid Pseudomonas aeruginosa associated with dysregulation in T-cell immunity to outer membrane Porin F. Am J Respir Crit Care Med. 2015;191:1250\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2249.2008.03697.x","volume":"153","author":"PT King","year":"2008","unstructured":"King PT, Ngui J, Gunawardena D, Holmes PW, Farmer MW, Holdsworth SR. Systemic humoral immunity to non-typeable Haemophilus influenzae. Clin Exp Immunol. 2008;153:376\u201384.","journal-title":"Clin Exp Immunol"},{"key":"811_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1164\/rccm.201502-0223OC","volume":"192","author":"MA Sze","year":"2015","unstructured":"Sze MA, Dimitriu PA, Suzuki M, McDonough JE, Campbell JD, Brothers JF, Erb-Downward JR, Huffnagle GB, Hayashi S, Elliott WM, Cooper J, Sin DD, Lenburg ME, Spira A, Mohn WW, Hogg JC. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192:438\u201345.","journal-title":"Am J Respir Crit Care Med"},{"key":"811_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1164\/rccm.200410-1332OC","volume":"172","author":"AK Sullivan","year":"2005","unstructured":"Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown KK, Kotzin BL, Voelkel NF, Fontenot AP. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med. 2005;172:590\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"811_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1164\/rccm.201212-2201ED","volume":"187","author":"KM Robinson","year":"2013","unstructured":"Robinson KM, Alcorn JF. T-cell immunotherapy in cystic fibrosis: weighing the risk\/reward. Am J Respir Crit Care Med. 2013;187(6):564.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0811-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T19:04:41Z","timestamp":1559156681000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0811-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0811-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the project was granted by the local NHS Research Ethics Committee, the NRES Committee North East \u2013 County Durham & Tees Valley (ref 12\/NE\/0248). All participants were adults who gave their informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"ADS has received medical education grant support for a UK bronchiectasis network from GSK, Gilead, Chiesi and Forest labs. ADS\u2019s employing institution receives fees for his work as Coordinating investigator in a phase III trial in Bronchiectasis sponsored by Bayer. All other authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"106"}}